20th Annual Scientific Sessions:
Cardiovascular disease in the metabolic syndrome: Linking metabolism, inflammation and heart disease
Graz, Austria 25-28 June 2023
10:00-18:00 |
Registration |
Trainee Workshop Chairs: Susanne Sattler (Graz, Austria), Michael Schwarzer (Jena, Germany) |
|
15:00-15:45 |
Single cell technologies Holger Winkels (Cologne, Germany) |
15:45-17:15 |
In vivo models of cardiovascular disease Dimitris Tsiantoulas (Vienna, Austria) Nikole Byrne (Graz, Austria) |
Opening Session |
|
18:00-18:15 |
Welcome from Organisers and SHVM President |
18:15-19:15 |
Keynote Lecture Chairs: Andreas Zirlik (Graz, Austria), Christian Schulze (Jena, Germany) Christoph Binder (Vienna, Austria) |
19:15 |
Informal dinner reception |
Session 1 – Cardiovascular treatment targets in the metabolic syndrome Chairs: Irene Lang (Vienna, Austria), Kieran Clarke (Oxford, United Kingdom) |
|
8:15-8:45 |
Harald Sourij (Graz, Austria) |
8:45-9:15 |
Coert Zuurbier (Amsterdam, The Netherlands) |
9:15-9:45 |
Gregory Shearer (University Park, PA, USA) |
9:45-10:00 |
Short talk: Jaetaek Kim (Seoul, South Korea) |
10:00-10:30 |
Coffee break |
10:30-11:00 |
Jingyuan Fu (Groningen, The Netherlands) |
11:00-11:30 |
Kurt Huber (Vienna, Austria) |
11:30-11:45 |
Short talk: Bellina Mushala (Pittsburgh, PA, USA) |
11:45-12:00 |
Short talk: Chloé David (Montréal, Canada) |
12:00-13:00 |
Lunch Symposium (sponsored by Abbott) Chairs: Andreas Zirlik (Graz, Austria), Daniel Zimpfer (Graz, Austria) Stefan Harb (Graz, Austria) Martin Benedikt (Graz, Austria) Albrecht Schmidt (Graz, Austria) |
13:00-13:30 |
Break |
Session 2 – Inflammation and immunity in myocardial and vascular disease Chairs: Dennis Wolf (Freiburg, Germany), Judy de Haan (Melbourne, Australia) |
|
13:30-14:00 |
Wei Liu (Manchester, UK) |
14:00-14:30 |
Pilar Alcaide (Boston, MA, USA) |
14:30-14:45 |
Short talk: Joost Luiken (Maastricht, The Netherlands) |
14:45-15:30 |
Special Lecture Jean-Claude Tardif (Montreal, Canada) |
15:30-16:00 |
Coffee break |
Session 3 – The "William C. Stanley" Early Investigator Award Chairs: Heiko Bugger (Graz, Austria), Jaetaek Kim (Seoul, South Korea) |
|
16:00-16:15 |
Sasha Smolgovsky (Boston, MA, USA) |
16:15-16:30 |
Stephanie Anderson (Oxford, United Kingdom) |
16:30-16:45 |
Lorenz Holzner (Cambridge, United Kingdom) |
16:45-17:00 |
Yung-Ting Hsiao (Osaka, Japan) |
17:00-18:00 |
Evening symposium (sponsored by Novartis) Chair: Andreas Zirlik (Graz, Austria) Heinz Drexel (Feldkirch, Austria), Thomas Stulnig (Vienna, Austria) Dietmar Hubner (Wels, Austria), Harald Sourij (Graz, Austria) All |
18:00-19:30 |
Poster Session I & Exhibitions |
19:30 |
Dinner |
Session 4 – Nutrients and diet in cardiometabolic disease Chairs: Adam Wende (Birmingham, AL, USA), Lisa Heather (Oxford, United Kingdom) |
|
8:30-9:00 |
Thomas Pulinilkunnil (St. John, Canada) |
9:00-9:30 |
Bettina Mittendorfer (St. Louis, MO, USA) |
9:30-10:00 |
Hyoung Kyu Kim (Busan, South Korea) |
10:00-10:30 |
Coffee break |
10:30-11:00 |
Guenter Haemmerle (Graz, Austria) |
11:00-11:30 |
Asa B. Gustafsson (San Diego, CA, USA) |
11:30-11:45 |
Short talk: Shubham Soni (Edmonton, Canada) |
11:45-12:00 |
Short talk: Matthew Rochowski (Stillwater, OK, USA) |
12:00-13:00 |
Lunch break |
13:00-14:00 |
Poster Session II & Exhibitions |
Session 5 – Metabolic disease and cardiovascular inflammation Chairs: Linda Peterson (Saint Louis, MO, USA), Christoph Binder (Vienna, Austria) |
|
14:00-15:00 |
Keynote Lecture Paul Ridker (Boston, MA, USA) |
15:00-15:30 |
Dennis Wolf (Freiburg, Germany) |
15:30-15:45 |
Coffee break |
15:45-16:15 |
Judy De Haan (Melbourne, Australia) |
16:15-17:05 |
Evening symposium (sponsored by Novo Nordisk) Chair: Heiko Bugger (Graz, Austria) Andreas Zirlik (Graz, Austria) Harald Sourij (Graz, Austria) |
17:05-17:15 |
Talk sponsored by Ablative Solutions Heiko Bugger (Graz, Austria) |
17:30-19:00 |
Networking activity |
20:00 |
Dinner |
8:30-9:30 |
"William C. Stanley" Award Lecture Chair: E. Dale Abel (Los Angeles, CA, USA) Christine Des Rosiers (Montreal, Canada) |
Session 6 – Dysregulated energy metabolism in heart failure Chairs: Veronique Lacombe (Stillwater, OK, USA), Simon Sedej (Graz, Austria) |
|
9:30-10:00 |
Senka Holzer (Graz, Austria) |
10:00-10:15 |
Short talk: Petra Kienesberger (Saint John, Canada) |
10:15-10:45 |
Coffee break |
10:45-11:15 |
Christoph Maack (Würzburg, Germany) |
11:15-11:45 |
Gabriele Schiattarella (Berlin, Germany) |
11:45-12:00 |
Short talk: Marine De Loof
(Brussels, Belgium) |
12:00-12:10 |
Invitation to SHVM 2024 |
12:10-12:20 |
Concluding Remarks Organisers and SHVM President |
12:20 |
Buffet Lunch |
When preparing your poster, please remember that its maximum size is A0 (841 x 1189 mm; width x height). Note that the orientation is portrait, not landscape.
Correct format... 
Wrong format...
You are expected to have your poster up the latest by lunchtime of the day of your session. Posters should be taken down after your session. Posters left behind will be removed and discarded by the venue personnel.
Poster presenters are required to be available for discussion during their assigned session. The distribution of posters in the two sessions is indicated below.
P1.1 · Stephanie Anderson (Oxford, United Kingdom)
Multiparametric immunometabolic phenotyping of the diabetic heart
P1.2 · Melina Amor (Graz, Austria)
Investigating the effects of MMP12 deficiency in cardiometabolic diseases
P1.3 · Michael G Atser (Vancouver, Canada)
The role of pyruvate dehydrogenase kinase 1 in triacylglycerol metabolism in differentiated H9C2 cardiomyocytes
P1.4 · Sun Sik Bae (Yangsan, South Korea)
Phospholipase C-β3 regulates vascular hyperplasia by the modulation of redox status
P1.5 · Neoma T Boardman (Tromsø, Norway)
Cardiac mitochondrial morphological and bioenergetic changes following breast cancer treatment
P1.6 · David Yin Cai (Hong Kong, China)
Knockdown of Hspa1b aggravates hypoxia/reoxygenation-induced cell injury and apoptosis via activation of p53 in H9C2 cardiomyocytes
P1.7 · Chloé David (Montreal, Canada)
The benefit of B vitamins in female heart function and survival in a mice model of heart failure involves cardiac and pulmonary fibrosis improvement and preserved circulating lipidome remodeling
P1.8 · Marine De Loof (Brussels, Belgium)
Acetylation of α-tubulin, a new player in cardiac glucose transport
P1.9 · Johannes Gollmer (Graz, Austria)
Molecular alterations of human diabetic heart disease revealed using single nucleus RNA sequencing
P1.10 · Stefan Groß (Greifswald, Germany)
The association between C24:0/C16:0 ceramide ratio and cardiorespiratory fitness is robust to effect modifications by age and sex in the general population: Results from the Study of Health in Pomerania (SHIP-START-1), Germany
P1.11 · Estelle Heyne (Jena, Germany)
Mitochondrial DNA differences in rats with high or low genetically determined exercise capacity affect cardiac function and metabolism
P1.12 · Lorenz M. W. Holzner (Cambridge, United Kingdom)
Liver specific HIF2α deletion modulates hepatic and cardiac mitochondrial function in a model of non-alcoholic fatty liver disease
P1.13 · Yung-Ting Hsiao (Osaka, Japan)
Circulating obesity associated pro-fibrotic protein as a brown adipokine promotes fibrosis in liver and heart
P1.14 · Guihwa Jeong (Gumi, South Korea)
NQO1-mediated activation of AMPK prevents diet-induced obesity and related complications
P1.15 · Agnieszka Karaś (Cracow, Poland)
The effect of vascular ageing and dyslipidaemia on vascular metabolism, endothelial function and arterial stiffness
P1.16 · Petra Kienesberger (Saint John, Canada)
Effect of cardiomyocyte-specific lipid phosphate phosphatase 3 (LPP3) overexpression on energy metabolism and metabolic cardiomyopathy
P1.17 · Mi Kyung Kim (Daegu, South Korea)
Metabolic switching from glycolysis to oxidative phosphorylation by PDH in macrophage ameliorates atherosclerosis by suppressing iNOS-induced foam cell formation
P1.18 · Katarzyna Kmiotek (London, United Kingdom)
Role of phosphofructokinase P in cardiac hypertrophy
P1.19 · Azra Kulovic-Sissawo (Graz, Austria)
Circulating neprilysin in pregnancy
P1.20 · Wei Li (Tromsø, Norway)
Fatty acids from Calanus oil-derived wax ester stimulate fatty acid oxidation and prevent palmitate-induced cell death
P1.21 · Yongwoon Lim (Hwasun-gun, South Korea)
The role of acetyltransferase PCAF in cardiac remodeling
P1.22 · Alice Marino (Brussels, Belgium)
Sodium myo-inositol cotransporter 1 affects cardiac hypertrophy in pressure-overloaded mouse hearts
P1.23 · Olurotimi O Mesubi (Baltimore, MD, USA)
Identifying transcriptomic changes that link O-GlcNAcylation to hyperglycemia-primed atrial fibrillation
P1.24 · Eun-Ji Min (Seoul, South Korea)
Porphyromonas gingivalis infection accelerates atherosclerosis through inducing oral and intestinal in western-fed murine model
P1.25 · Akiyuki Nishimura (Okazaki, Japan)
Sulfide metabolism has principal roles in ischemic resistance of the heart
P1.26 · Jeanne Pottien (Greifswald, Germany)
Individual trajectories of cardiorespiratory fitness (VO2max) over time - An underrated predictor of all-cause mortality? Joint modeling of longitudinal and survival data over several follow-ups of the Study of Health in Pomerania (SHIP-START) in Germany
P1.27 · Christina M. Reumiller (London, United Kingdom)
Regulation of cardiac glucose intermediary metabolism by c-Myc during exercise
P1.28 · Marcel Rose (Jena, Germany)
Atrial mitochondrial respiratory chain complex activity in human hearts differs from ventricular and septal activities
P1.29 · Lukas Schönbacher (Graz, Austria)
Associations of prenatal human milk oligosaccharides (HMOs) with maternal BMI and lipid profile in overweight and obese pregnant women
P1.30 · Abhipree Sharma (Parkville, Australia)
Sex differences in the cardiometabolic phenotype of mice – impact of high fat diet and the SGLT2i, dapagliflozin
P1.31 · Sasha A Smolgovsky (Boston, MA, USA)
Dysregulation of the IRE1α-XBP1s axis directs T cell inflammation in experimental Heart Failure with Preserved Ejection Fraction (HFpEF)
P1.32 · Shubham Soni (Edmonton, Canada)
Gestational ketone supplementation during perinatal iron deficiency may protect against cardiac damage in the neonatal offspring
P1.33 · Fang Wang (Maastricht, Netherlands)
Quercetin ameliorates insulin-stimulated glucose uptake in a cardiomyocyte model of lipid overload
P1.34 · Elisa Weiss (Graz, Austria)
Higher gestational weight gain is associated with impaired wound healing and reduced expression of long non-coding RNA KLRK1-AS1 in neonatal endothelial progenitor cells
P1.35 · Myrthe Willemars (Maastricht, Netherlands)
Sex-specific re-balancing of cellular energy substrate metabolism to prevent pressure overload-induced hypertrophy
P1.36 · Anna Zoccarato (London, United Kingdom)
Constitutive activation of NRF2 induces glucose metabolic reprogramming in the heart and mediates cardio-protection via upregulation of the pentose phosphate pathway (PPP)
P2.1 · Jihun Ahn (Daejeon, South Korea)
Three-year clinical outcomes of dual-drug-eluting cilotax stent and everolimus-eluting stents in acute myocardial infarction patients: results from the Korea Acute Myocardial Infarction Registry (KAMIR)
P2.2 · Jihun Ahn (Daejeon, South Korea)
Comparison of the safety and the efficacy between high-intensity statin therapy and dual lipid-lowering strategy with moderate-intensity statin therapy plus ezetimibe on the paitents who underwent percutaneous coronary intervention using drug eluting stent
P2.4 · Martin Benedikt (Graz, Austria)
Impact of the SGLT2-inhibitor Empagliflozin on inflammatory biomarkers in acute myocardial infarction– a post-hoc analysis of the EMMY trial
P2.5 · Nikole Byrne (Graz, Austria)
Nicotinamide mononucleotide supplementation attenuates atherosclerosis and diastolic dysfunction in western diet-fed Ldlr-/- mice
P2.6 · Eva Correia (Rouen, France)
Impact of curative perfusion with hypersosmolar lactate solution on cardiovascular dysfunction in a rat model of sepsis
P2.7 · Miles De Blasio (Melbourne, Australia)
Cardiac-selective adiponectin receptor gene therapy as a therapeutic target for cardiomyopathy in a mouse model of type 2 diabetes (T2D)
P2.8 · Natacha Fourny (Brussels, Belgium)
Contribution of protein O-GlcNAcylation to the development of cardiac dysfunction in obese diabetic mice
P2.9 · Stefan Groß (Greifswald, Germany)
Inverse associations of markers for cardiorespiratory fitness with high-sensitive CRP and white blood cell count are pronounced by metabolic syndrome status in the general population: Results from two cohorts of the Study of Health in Pomerania (SHIP-START-2, SHIP-TREND-0), Germany
P2.10 · Helena Heilke (Greifswald, Germany)
Individual LDL-c trajectories over time and all-cause mortality in Northeast Germany: Joint modeling of longitudinal and survival data over four follow-ups of the Study of Health in Pomerania (SHIP-START-0/1/2/3) in Germany
P2.11 · Martijn Hoes (Maastricht, Netherlands)
Novel autologous stem cell-derived cardiac tissues for translational research
P2.12 · Soon Jun Hong (Seoul, South Korea)
Comparison of effects of telmisartan and valsartan on neointima volume and atherosclerosis progression at 8 months after zotarolimus-eluting stent implantation in hypertensive type 2 diabetic patients
P2.13 · Jae-Han Jeon (Daegu, South Korea)
Vascular calcification is attenuated by activation of pyruvate flux
P2.14 · Patrycja Kaczara (Cracow, Poland)
Pharmacological regulation of platelet energy metabolism as a way to develop innovative antiplatelet therapies
P2.15 · Ahmed Karoui (Orsay, France)
Impact of Nicotinamide Riboside Kinase 2 overexpression and NAD precursor nicotinamide riboside treatment in response to endoplasmic reticulum stress induction in the heart
P2.16 · Jaetaek Kim (Seoul, South Korea)
Insulin signaling is critical for sinoatrial node maintenance and function
P2.17 · Sung Joon Kim (Seoul, South Korea)
Role of myofilament-associated nNOS for Ca2+ desensitization via troponin I phosphorylation in the right ventricular cardiomyocytes of rats
P2.18 · Alice E. Knapton (Cambridge, United Kingdom)
Amylin aggregation and suppression of mitochondrial respiratory capacity in the diabetic heart
P2.19 · Soyeon Kwon (Seoul, South Korea)
Extracellular vimentin induces ER stress in adipocytes
P2.20 · Byung-Kwan Lim (Goesan-gun, South Korea)
PDH activation reduced acute inflammation in CVB3-induced myocarditis
P2.21 · Craig Lygate (Oxford, United Kingdom)
What does homoarginine do in the heart? A hypothesis generating -omics study
P2.22 · Matthew D. Martens (Edmonton, Canada)
Reactive oxygen species modulator 1 (ROMO1) plays an obligate role in cardiomyocyte hypertrophy
P2.23 · Lauriane Y. Michel (Brussels, Belgium)
Protection against hypertrophic remodeling and oxidative stress by cardiac beta3-adrenergic receptors is mediated by NRF2 activation and the pentose phosphate pathway
P2.24 · Bellina Mushala (Pittsburgh, PA, USA)
GPR19 is an orphan receptor that mediates cardio-hepatic metabolic crosstalk in obesity
P2.25 · Mariola Olkowicz (Cracow, Poland)
Key role of 12-lipoxygenase in the regulation of vascular metabolism in atherogenic dyslipidaemia
P2.26 · Julie Rennison (Cleveland, OH, USA)
Complex I protein expression is increased in left atrium of patients in atrial fibrillation
P2.27 · Matthew Rochowski (Stillwater, OK, USA)
Cardiac-specific SERCA overexpression improves cardiac and systemic glucose metabolism during diabetes
P2.28 · Michele Russo (Turin, Italy)
Unravelling the metabolic aspects of doxorubicin-induced cardiotoxicity
P2.29 · Sarah M Schumacher (Cleveland, OH, USA)
Sex differences in cardiometabolic remodeling revealed by cardiac amino-terminal GRK2 peptide (βARKnt) regulation of AS160
P2.30 · Ippei Shimizu (Osaka, Japan)
Capillaries as a therapeutic target for heart failure
P2.31 · Juhyun Song (Hwasun, South Korea)
Lipocalin 2 controls neuronal cell via AKT signaling in a bile duct ligation mouse model
P2.32 · Ivan Vosko (Graz, Austria)
Distinct plasma ceramides predict cardiovascular mortality in diabetic and non-diabetic subjects with coronary artery disease
P2.33 · Marie-Therese Weiser-Fuchs (Graz, Austria)
Endothelium-modulating human milk oligosaccharides (HMOs) in maternal serum change during oral glucose tolerance test
P2.34 · David Weissman (Würzburg, Germany)
Cardiac fibroblast metabolism in Fabry cardiomyopathy: a window into pathogenesis and therapeutic targets
P2.35 · Franziska Wittmann (Vienna, Austria)
The influence of cardiovascular risk factors on preoperative vein graft quality in patients undergoing coronary artery bypass grafting